Envoy Medical, Inc. Class A Common Stock
COCH Real Time Price USDRecent trades of COCH by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by COCH's directors and management
Government lobbying spending instances
-
$50,000 Oct 18, 2024 Issue: Medicare/Medicaid
-
$60,000 Oct 16, 2024 Issue: Health Issues
-
$120,000 Jul 19, 2024 Issue: Medicare/Medicaid
-
$50,000 Jul 17, 2024 Issue: Health Issues
-
$130,000 Apr 19, 2024 Issue: Medicare/Medicaid
-
$60,000 Apr 16, 2024 Issue: Health Issues
-
$70,000 Jan 19, 2024 Issue: Medicare/Medicaid
-
$50,000 Oct 19, 2023 Issue: Medicare/Medicaid Defense Budget/Appropriations
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of COCH in WallStreetBets Daily Discussion
Recent insights relating to COCH
Recent picks made for COCH stock on CNBC
ETFs with the largest estimated holdings in COCH
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view COCH Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.